Prenatal exposure to ethanol induces aberrant tangential migration of corticopetal 17
Introduction 31
Binge-type exposure of the embryonic mouse brain to a moderate level of ethanol leads 32 to interneuronopathy, hallmarked by aberrant tangential migration of corticopetal GABAergic 33 interneurons derived from the medial ganglionic eminence (MGE) (Skorput et al., 2015) . 34
Interneuronopathies are widely implicated in neurodevelopmental disorders (Catterall, 2018 ; Surveillance System for the years 2015 -2017 show self-reported rates of current drinking, and 38 binge drinking (> 4 drinks) within the past 30 days to be 11.5% and 3.9%, respectively, among 39 of targeted medication and broadly applicable treatment strategies. 48
The more efficacious current treatments for FASD rely primarily on postnatal behavioral 49 therapy (Nash et al., 2017) , or pharmaceutics aimed to treat the symptoms, rather than the 50 etiology, of this neurodevelopmental disorder (Peadon et al., 2009; Rowles and Findling, 2010) . 51
Indeed, there is a societal need to uncover the cellular and subcellular underpinnings by which 52 ethanol adversely affects neurodevelopmental processes (Ismail et Building on our previous work (Cuzon et al., 2008 (Cuzon et al., , 2006 , we hypothesized that 64 ethanol's positive allosteric modulation of GABAA receptors (GABAAR) expressed on migrating 4 neuroblasts is the mechanism by which in utero ethanol exposure causes enduring 66 interneuronopathy in models of FASD (Skorput et al., 2015; Skorput and Yeh, 2016) . In these 67 immature neurons, GABAAR activation results in membrane depolarization (Ben-Ari, 2014, 68
2002; Owens and Kriegstein, 2002) . This paradoxical depolarizing action has been postulated to 69 drive the corticopetal tangential migration of GABAergic interneurons during corticogenesis 70 To this end, we targeted the chloride importing Na + -K + -2Clisoform 1 cotransporter 76 (NKCC1) because it is expressed at high levels in the embryonic brain when its activity 77 predominates over that of the chloride exporting K + -Clco-transporter (KCC2). This differential 78 activity results in a net higher [Cl -]i compared to [Cl -]o. As such, the reversal potential for 79 chloride, and that of GABA-activated responses (EGABA), is set at a membrane potential that is 80 depolarized relative to the resting membrane potential. Thus, GABAAR activation causes 81 chloride extrusion and membrane depolarization in these migrating neuroblasts (Ben-Ari, 2014, 82 2002; Owens and Kriegstein, 2002) . The loop diuretic bumetanide is an NKCC1 antagonist that 83 shifts the EGABA of embryonic neuroblasts to a more negative membrane potential when 84 administered maternally (Wang and Kriegstein, 2011) . Given these considerations, we tested 85 the hypothesis that in utero treatment with bumetanide during the period of prenatal ethanol 86 exposure will mitigate manifestation of prenatal ethanol-induced aberrant tangential migration, 87 and prevent deficits in behavioral flexibility. 88
The timing of gestational exposure to ethanol is a key determinant of the diagnostic 89 outcome of FASD (May et al., 2013; Pruett et al., 2013) . Corticogenesis occurs in earnest during 90 the mid-first trimester when the developing brain is highly vulnerable to insult by ethanol (Ayoola 91 simulates an early gestational, mid-first trimester human equivalent, exposure to binge-type 93 maternal ethanol consumption from embryonic day (E) 13.5 -E16.5 (Clancy et al., 2001; 94 Skorput et al., 2015) . Using this model we demonstrated enhanced entry of MGE-derived 95
GABAergic interneurons into the prefrontal cortex (PFC), a persistent increase in the number of 96 PV + interneurons in the young adult PFC, and impairment in the PFC-dependent behavioral 97 flexibility of offspring (Skorput et al., 2015) . 98
In the present study, we used this mouse model to assess whether the NKCC1 99 cotransporter is a tractable pharmacological target for normalizing in utero ethanol exposure-100 induced escalation of tangential migration to the prefrontal cortex. We report here that ethanol 101 induces a shift in EGABA toward a more depolarized potential, accounting at least in part for 102 ethanol's potentiation of GABA-induced depolarizing responses in embryonic MGE-derived 103 GABAergic interneurons. In the short term, antagonizing NKCC1 with bumetanide mitigated 104 ethanol-induced aberrant tangential migration. In the long-term, bumetanide treatment in vivo 105 prevented prenatal ethanol exposure-induced interneuronopathy in the prefrontal cortex, and 106 the associated deficits in PFC-dependent behavioral flexibility. Our findings support the 107 feasibility of a pharmacological strategy to target NKCC1 for the management of FASD. 108
Results 109
Ethanol induces a depolarizing shift in the GABA reversal potential of embryonic MGE-derived 110
GABAergic cortical interneurons that is normalized by the NKCC1 inhibitor bumetanide 111
Nkx2.1 + embryonic MGE-derived GABAergic cortical interneurons were identified by 112 tdTomato fluorescence and targeted for perforated patch clamp recording in acute (200 m) 113 telencephalic slices obtained from E14.5 -16.5 Nkx2.1Cre/Ai14 mouse brain ( Fig. 1a ). GABA 114 (50 M), ethanol (6.5 mM) and aCSF were loaded into separate barrels of a multi-barrel drug 115 pipette and focally applied by regulated pressure either individually, or in combination, in the 116 immediate vicinity of the cell under study ( Fig. 1a ). Since GABA-induced membrane 117 depolarization is prevalent in many types of immature neurons early in brain development, and 118 has been postulated to promote the tangential migration of GABAergic cortical interneurons 119 Kriegstein, 2009), we asked whether exogenously-applied GABA depolarized embryonic 121
Nkx2.1 + cortical interneurons. In Figure 1b , the representative sets of digitized raw traces 122 display current responses to 500 ms pressure applications of 50 M GABA monitored at varying 123 holding potentials before (black traces) and during ethanol exposure (red traces). The polarity 124 and peak amplitude of each GABA response were plotted as a function of the corresponding 125 holding potential, and the intercept of the current-voltage plot along the abscissa was used to 126 estimate EGABA. Figure 1c shows linear regression of the group mean data. The control mean 127 EGABA (dotted black line in Fig. 1c ) was -23.18  1.45 mV, which was significantly more 128 depolarized than the mean resting membrane potential, estimated in whole-cell mode (dotted 129 blue line in Fig. 1c ; -41.9  2.3 mV; unpaired t-test, P<0.01). Importantly, Figure 1c illustrates 130 that ethanol exposure shifted EGABA rightward relative to that assessed during the control epoch 131 (dotted red line). Figure 1d illustrates the mean change in EGABA for each litter before and during 132 ethanol exposure, indicating that the mean EGABA of control cells was shifted to significantly 133 more depolarized membrane potentials with exposure to 6.5 mM ethanol ( Fig. 1d ; -16.52  0.93 134 mV; P=0.0043). The finding that ethanol exposure results in a depolarizing shift in EGABA 135
suggests that it increases [Cl -]i and thus, chloride drive. 136
Pretreatment of acute E14.5 -16.5 telencephalic slices for 30 minutes with the NKCC1 137 antagonist bumetanide (20 µM) normalized the ethanol-induced depolarization of EGABA to 138 control levels ( Fig. 1e ; EtOH+Bumet; -24.82  2.52 mV; n=5 litters, 13 cells total; P = 0.56). The 139 basis of this normalization is likely a functional antagonism as bumetanide pretreatment 140 significantly hyperpolarized EGABA in Nkx2.1 + GABAergic interneurons compared to controls ( Fig.  141 1e; Bumet; -34.17  4.02 mV; n=5 litters, 13 cells total; P = 0.004), and the magnitude of the 142 depolarizing shift in EGABA induced by exposure to 6.5mM ethanol was not effected by 143 bumetanide pretreatment ( Fig. 1f ; Control; 27.08  5.61 mV; Bumet pretreatment; -25.38  6.41 144 mV; P=0.37). These results prompted us to ask whether bumetanide treatment may restrict the 145 enhanced chloride driving force caused by ethanol-induced increases in [Cl -]i to thus mitigate 146 ethanol's potentiation of depolarizing GABAAR activity in embryonic GABAergic interneurons. 147
Bumetanide attenuates ethanol-induced potentiation of depolarizing GABA responses in 148 embryonic MGE-derived GABAergic cortical interneurons 149
In perforated patch-clamp recordings, we analyzed current response amplitudes of 150
GABAergic cortical interneurons held at -60 mV to 500 ms applications of 50 M GABA before 151 and during 6.5 mM ethanol exposure in E14.5-E16.5 telencephalic slices ( Fig. 2a , inset). Figure  152 2a illustrates that, relative to baseline conditions, the mean GABA response amplitude during EtOH+Bumet NS ̅ = 2.49x10 -3 ± 1.45x10 -5 cells/μm 2 , 5 brains from 2 litters; P >0.999), and a 206 significant increase in Nkx2.1 + cell density persisted in the E16.5 PFC compared to controls 207 ( Fig. 4b ; P = 0.00481). 208
We next sought to simulate a more clinically relevant route of bumetanide administration. 209
We asked whether bumetanide, administered orally in the course of ad lib feeding, can prevent 210 the in vivo effects of binge-type ethanol exposure on the entry of MGE-derived interneurons to 211 the embryonic PFC. To this end, a Na + bumetanide salt (320, 130, 13, 1.3 mg/kg food) was 212 dissolved in the 5% w/w ethanol containing liquid diet fed to binge ethanol-consuming dams. EtOH+Bumet 1.3mg/kg food ̅ = 2.78x10 -3 ± 1.55x10 -4 cells/μm 2 , 5 brains from 2 litters; 225
EtOH+Bumet 13mg/kg food ̅ = 2.50x10 -3 ± 1.81x10 -4 cells/μm 2 , 6 brains from 2 litters; P = 226 1.65x10 -5 , P = 0.00152 respectively) and Nkx2.1 + cell densities were not significantly decreased 227 
Treatment of binge ethanol consuming dams with bumetanide prevents interneuronopathy in the 232

PFC of young adult offspring 233
To determine the long-term effect of NKCC1 antagonism on ethanol-induced 234 interneuronopathy, we quantified the distribution of PV + interneurons in the PFC of young adult 235 mice that had been exposed prenatally to binge-type ethanol without or with bumetanide co-236 treatment (daily maternal i.p. injection, 0.15mg/kg, E13.5 -E16.5). The PFC was divided into 237 subregions (anterior cingulate cortex (ACC), prelimbic (PL), infralimbic (IL)), and subdivided by 238 cortical layer, based on the cytoarchitecture as revealed by DAPI counterstaining. Previously, we reported a layer V-specific increase in PV + interneurons in the young adult mPFC following 240 binge-type ethanol exposure in utero (Skorput et al., 2015) . In comparison, the number of PV + 241 interneurons in the PFC of binge-type ethanol-exposed offspring treated in utero with 242 bumetanide was significantly lower in layer V of the ACC (Fig. 5a&b ; EtOH ̅ = 47.7 ± 3.5, 9 243 brains from 4 litters; EtOH+Bumet ̅ = 37.3 ± 2.0, 4 brains from 2 litters; P = 0.00429) and the PL 244 region ( Fig. 5a&c ; EtOH ̅ = 30.9 ± 3.0, 9 brains from 4 litters; EtOH+Bumet ̅ = 19.1 ± 1.5, 4 245 brains from 2 litters; P = 3.27x10 -5 ). The increase in PV + interneurons of the ACC induced by in 246 utero ethanol exposure was completely prevented by bumetanide co-treatment; there was no 247 significant difference in the number of PV + interneurons in layer V of the ACC between offspring 248 exposed to ethanol in utero that received maternal bumetanide treatment and controls ( To determine if the observed normalizing effect of maternal bumetanide treatment on 263 tangential migration also mitigates deficits in PFC-dependent behavioral flexibility, we compared 264 the performance of offspring exposed in utero to binge-type ethanol without and with maternal 265 bumetanide treatment (0.15 mg/kg i.p, dissolved in DMSO) on the modified Barnes maze ( Fig.  266 6). Young adult offspring exposed to binge-type ethanol in utero and treated maternally with 267 bumetanide exhibited no significant difference in the number of errors committed during the 268 training and testing phases compared with ethanol-exposed, and control, offspring ( Fig. 6a ; 269
Control 14 offspring from 4 litters; EtOH 19 offspring from 4 litters; EtOH+Bumet 8 offspring from 270 2 litters; P >0.427). 271
As previously reported (Skorput et al., 2015) , the errors committed by ethanol-exposed 272 offspring increased on day one of the reversal phase (Fig 6a; Control ̅ = 2.68 ± 0.37 errors; 273
EtOH ̅ = 4.78 ± 0.41 errors; P = 0.00192). Offspring born to ethanol consuming dams treated 274 with bumetanide, however, showed no significant increase in errors compared to controls ( Fig  275   6a ; EtOH+Bumet i.p. ̅ = 3.28 ± 0.51 errors; P >0.999), and was significantly lower than those 276 committed by ethanol-exposed offspring not treated maternally with bumetanide ( Fig. 6b ; P = 277 0.0433). Further analysis revealed that the increase in errors exhibited by ethanol exposed 278 offspring on day one of the reversal phase were committed in the opposite quadrant (Fig 6b; 279
Control ̅ = 0.92 ± 0.23 errors; EtOH ̅ = 1.88 ± 0.15 errors; P = 0.00036). In contrast, the number 280 of these perseverative errors committed by ethanol exposed offspring maternally treated with 281 bumetanide was not significantly different from controls ( Fig. 6b ; EtOH+Bumet ̅ = 1.21 ± 0.31 282 errors; P = 0.0745). Thus, maternal bumetanide treatment prevented perseverative behaviors, 283 which are indicative of reduced behavioral flexibility, in offspring exposed to ethanol in utero. 284
Discussion 285
The results reported here advance our understanding of depolarizing GABAergic 286 influence on tangential migration, and demonstrate that treatment of ethanol consuming dams 287 with bumetanide can prevent persistent interneuronopathy in ethanol-exposed offspring. These 288 results offer insights into the developmental pathophysiology of FASD, and posit therapeutic 289 avenues for novel treatments. 290
As shown by our electrophysiological studies, ethanol-induced depolarizing shifts in 291 EGABA of similar magnitude without and with bumetanide pretreatment, suggesting that the 292 depolarizing shift of EGABA induced by ethanol occurs independent of NKCC1 function. Further, 293
as NKCC1 antagonism alone significantly shifted EGABA to more hyperpolarized values, it is likely 294 that bumetanide does not directly inhibit the ethanol-induced depolarizing shift in EGABA, but 295 rather normalizes it via an opposing mechanism separate from NKCC1. This normalization of 296 The ability of bumetanide to prevent aberrant tangential migration following in utero 308 binge-type exposure to ethanol at the height of interneuron migration sheds light on the 309 mechanistic basis of ethanol's enhancement of tangential migration. Maternal injection with a 310 similar dose of bumetanide has been shown to shift the reversal potential of GABA mediated 311 currents in neonatal cortical neurons, suggesting that maternally administered bumetanide 312 reaches the embryonic brain (Wang and Kriegstein, 2011) . With the doses of bumetanide used 313 here, we did not see a reduction in tangential migration below levels seen in control animals, suggesting the existence of a therapeutic window in which bumetanide treatment can inhibit the 315 aberrant migration induced by ethanol exposure in utero while not significantly effecting 316 endogenous migration. Despite not impacting tangential migration in vitro, bumetanide at 20 µM 317 did significantly shift the EGABA of migrating interneurons to more hyperpolarized values (Fig.  318 1e). This discrepancy may be due to the limited magnitude of the shift in EGABA, and/or a weeks pregnant, and reports binge drinking within that period of time). Therefore, the next step 356 for this work is clearly to assess bumetanide's ability to prevent or mitigate the long-term 357 deleterious effects of in utero ethanol exposure when administered at times after ethanol 358
exposure. 359
While it is likely that some enhancement of tangential migration has occurred initially, it 360 is possible that bumetanide treatment will slow migration of subsequent interneurons to the 361 cortex. Alternatively, it may be that bumetanide treatment later in development, when cortical Hatfield, PA). The slices were stored immersed in a reservoir of aCSF at room temperature for 402 approximately one hour prior to use for electrophysiological experiments. For consistency, we 403 used only slices in which the MGE and LGE were clearly demarcated by the ganglionic sulcus. 404
Perforated patch clamp recording: 405
Gramicidin perforated patch clamp recording was used in order to preserve the 406 intracellular chloride (Cl -) concentration (Ebihara et al., 1995) . An acute 200µm telencephalic 407 slice obtained from E14.5-E16.5 Nkx2.1Cre/Ai14 brain was transferred to a recording chamber, 408 stabilized by an overlaying platinum ring strung with plastic threads, and maintained at 32-34º C 409 on a heated stage fit onto a fixed-stage upright microscope (BX51WI, Olympus, Melville, NY). Drug solutions were loaded into separate barrels of a 6-barrel drug pipette assembly that 450 was navigated to within 10 m of the soma of the cell under study and applied using regulated 451 pulses of pressure (≤ 3 p.s.i.; Picospritzer, General Valve Corporation, Fairfield, NJ) ( Fig. 1a) . 452
The timing and the duration of the pressure pulses were controlled by a digital multi-channel 453 timing unit and pulse generator (Pulsemaster A300, WPI, Sarasota, FL). One of the barrels of 454 the multi-barrel assembly was routinely filled with aCSF, which was applied between drug 455 applications to clear drugs from the vicinity of the cell and to control for mechanical artifacts that 456 can occur occasionally due to bulk flow. 457
Organotypic embryonic slice cultures 458
Time-pregnant female mice were sacrificed by carbon dioxide asphyxiation at E14.5. 459
Embryos were removed, and the brains were harvested and processed as described previously 460 (Cuzon et al., 2008) . Briefly, the embryos were decapitated, the brains were isolated with aid of 461 a dissecting microscope, and immersed in ice-cold slicing medium (1:1 F12:DMEM) oxygenated 462 by bubbling with 95% O2 5% CO2. Brains were then embedded in 3.5% low melting point 463 agarose in 1:1 F12:DMEM. Using a vibrating microtome (Electron Microscopy Sciences), 464
CO2. 466
The embryonic organotypic slices were maintained on a fine nylon mesh supported on a 467 mid-gauged U-shaped platinum wire in a 35-mm round Petri dish. A small volume of sterile 468 filtered culture media (0.8 ml) (1:1 F12/DMEM, 1% penicillin/streptomycin, 1.2% 6 mg/ml 469 glucose in DMEM, 10% fetal bovine serum, and 1% L-glutamine) was added to achieve air-470 liquid interface. Slice cultures were placed in a humidified incubator (37° C, 5% CO2) for 1hr, 471 after which the following culture media were prepared and used to replenish sister slice cultures: 472 
Binge-type maternal ethanol consumption and in vivo bumetanide administration 483
In the in vivo experiments, ethanol exposure in utero was begun on E13.5 and 484 terminated on E16.5 in order to be within the timeframe when tangential migration of MGE-485 derived cortical interneuron is at its peak in mouse Rubenstein, 2001; Parnavelas, 2000) . Pregnant dams were individually housed and assigned to 488 one of two groups: ethanol-fed, or control-fed. Mice were maintained under normal 12/12 hr 489 (5% w/w; ethanol-fed group) or an isocaloric control diet containing maltose (control-fed group); 491 water was available ad libitum. The liquid food was replenished daily between 3:00 and 5:00 492 PM, when the amount consumed was measured and the dams weighed. Mice were maintained 493 on their respective diets from E13.5 until E16.5, after which they were returned to standard 494 chow. Dam blood alcohol level (BAL; 80±21 mg/dl) was assessed using an Analox Instruments 495 GM7 series analyzer (Lunenburg, MA), with blood collected via the tail vein at 11:30 PM on 496 E15.5. Dams subjected to our regimen of binge-type gestational ethanol consumption carried 497 their offspring to full term, and litter size was unaffected (7.50 ± 0.62 for Control pups; 7.67 ± 498 0.76 for EtOH-exposed pups; unpaired t-test P>0.05 (Skorput et al., 2015) ). 499
Bumetanide solution for intraperitoneal (i.p.) injection was prepared fresh from powder at 500 the start of each binge epoch by adding bumetanide to normal saline at 0.015 mg/ml or by 501 dissolving bumetanide in DMSO at 20 mg/ml stock concentration that was diluted to 0.015 502 mg/ml in normal saline for daily i.p. injections. Bumetanide was injected into binge ethanol-503 consuming dams at 10 ml/kg, yielding a dose of 0.15 mg/kg/day over the three-day binge 504 period. Bumetanide delivery via liquid food was accomplished by dissolving the bumetanide 505 sodium salt in the water used to make 5% ethanol-containing liquid food at; 1.3, 13, 130, 320 506 mg of bumetanide salt per kg of food. vitro experiments, histological sections of organotypic slice cultures were imaged at 4X and the 543 images were montaged to allow visualization of the cortex from the corticostriate junction to the 544 dorsal apex. One hundred micron consecutive bins spanning the thickness of the cortex were 545 organized along the ventral to dorsal extent of the cortex, with the starting point of the first bin 546 aligned at the corticostriate juncture (Cuzon et al., 2006) . The Nkx2.1 + MGE-derived GABAergic 547 interneurons within these bins were quantified by trained experimenters blinded to the 548 experimental condition using Fiji's cell counting tool. 549
Modified Barnes Maze 550
Young adult mice (P58-70) were tested behaviorally using a modified Barnes maze as 551 previously reported (Koopmans et al., 2003; Skorput et al., 2015) . Briefly, the maze consisted of 552 twelve equally-spaced holes around a circular wall (d = 95cm), with spatial cues (large red 553 letters) placed between the holes along the interior surface of the circular wall. Each mouse was 554 randomly assigned an escape hole within a quadrant. All other holes were plugged. Mice were 555 trained to find the escape hole with four 4-min trials per day for four consecutive days. Each trial 556 ended when the mouse entered the escape hole. The mouse was then returned to its home 557 cage (escape reinforcement). Following the training phase, the mice were rested for two days, 558 and then tested for their ability to recall the position of the escape hole on the next two days, 559 with four 4-min trials per day (testing phase). After two days of testing, the location of the 560 escape hole was switched to the hole directly opposite its initial position (reversal phase). Mice 561 were then tested for their ability to find the reversed escape hole with four 4-min trials per day 562 over the subsequent two days. 563
At the beginning of each trial, the mouse was placed in the center of the maze and 564 covered with a start box; time began when the box was removed. Latency to enter escape hole, 565 time per quadrant; Home (H), Clockwise (CW), Opposite (Opp.), Counter Clockwise (CCW) 566 were made via video tracking software running an overhead camera hung at a set distance from 568 the surface of the maze. During a trial, errors made (nose pokes in non-escape hole) and their 569 locations, were recorded manually by observers on opposite sides of the arena. 570
Statistics 571
All young adult histological data were acquired from the defined subregions and layers 572 within the PFC. All groups consisted of data acquired from ten 30 μm tissue sections per animal 573 (n=1: 1 animal =10 sections) from a minimum three individual animals of multiple litters. For 574 electrophysiological data, n refers to the number of litters used in order to minimize litter effects, 575 and the total number of cells recorded for each experiment is noted in results. Group means 576
were compared by unpaired t-test, one-way ANOVA or two-way ANOVA with appropriate post-577 hoc test as indicated, and reported in figure legends, and reported as mean ( ̅ ) ± standard error 578 in the results section. Reported exact P values are multiplicity adjusted for ANOVA testing of 579 multiple comparisons. We note that previously published counts of prenatal and postnatal 580 cortical interneurons and behavioral data obtained from control, and prenatal binge ethanol-581 exposed young adult mice (Skorput et al., 2015) were included for comparison with the 582 bumetanide-treated cohort in the present study. This was justified as, in practice, the 583 experiments involving all three cohorts were conducted in parallel, and reporting of the 584 bumetanide data required the subsequent mechanistic studies reported here. 
